Members |
targetComponentId |
Chronic ulcer of other specified site |
Chronic ulcer of skin |
Chronic uremia |
Chronic renal failure |
Kronisk gul leveratrofi |
Chronic necrosis of liver |
Chronobiologic disorder |
Abnormal chronobiologic state (finding) |
Chryseobacterium meningosepticum |
Elizabethkingia meningoseptica (organism) |
Chryseobacterium miricola |
Elizabethkingia miricola (organism) |
Chryseobacterium scopthalmum |
Chryseobacterium scophthalmum (organism) |
Chryseomonas-art |
Pseudomonas |
Chudley Lowry Hoar syndrome |
A rare X-linked syndromic intellectual disability characterized by profound developmental delay, facial dysmorphism, genital abnormalities and alpha thalassemia. |
chymopapainekstrakt |
Product containing chymopapain (medicinal product) |
ciclesonid 160 µg inhalator |
Product containing only ciclesonide in pulmonary dose form (medicinal product form) |
ciclesonid 80 µg inhalator |
Product containing only ciclesonide in pulmonary dose form (medicinal product form) |
ciclopirox 0,77 % suspension til topikal anvendelse |
Product containing precisely ciclopirox (as ciclopirox olamine) 7.7 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
ciclopiroxolamin 8 % opløsning |
Product containing precisely ciclopirox 80 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
cidofovir 75 mg/ml koncentrat til infusionsvæske, hætteglas a 5 ml |
Cidofovir 75 mg/mL solution for injection |
Cidofovir 75mg/mL injection |
Cidofovir 75 mg/mL solution for injection |
Cidofovir 75mg/mL injection solution 5mL vial |
Cidofovir 75 mg/mL solution for injection |
Cigarette cough |
Smokers' cough |
Forgiftning med fisk |
Ciguatoxin causing toxic effect |
allergi over for cilazapril |
Non-allergic hypersensitivity to cilazapril (finding) |
Cilioretinal artery sparing |
Cilioretinal artery sparing (finding) |
Cimetidine hydrochloride 300mg/50 mL injection |
Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Cimetidine hydrochloride 300mg/50mL(0.9%) conventional release solution for infusion 50mL bag |
Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
cimetidinhydrochlorid 300 mg/50 ml (0,9 %) opløsning til intravenøs anvendelse, pose a 50 ml |
Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Cineradiography NOS |
Cineradiography |
Cineradiography NOS |
Cineradiography |
ciprofloxacin 0,2 % + hydrocortison 1 % øreopløsning |
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) |
ciprofloxacin 1000 mg tablet med modificeret udløsning |
Ciprofloxacin only product in oral dose form |
Ciprofloxacin 1000mg prolonged-release oral tablet |
Ciprofloxacin only product in oral dose form |
Ciprofloxacin 10g/100mL oral suspension |
Ciprofloxacin 100 mg/mL oral suspension |
Ciprofloxacin 200mg solution |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
Ciprofloxacin 200mg/100mL |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
ciprofloxacin 200 mg/100 ml injektionsvæske, opløsning til intravenøs anvendelse, færdig blanding i pose a 100 ml |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
Ciprofloxacin 200mg/bag injection |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
Ciprofloxacin 2mg/mL |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
ciprofloxacin 2 mg/ml infusionsvæske, opløsning, flaske a 200 ml |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
ciprofloxacin 2 mg/ml infusionsvæske, opløsning, flaske a 50 ml |
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
ciprofloxacin 500 mg tablet med modificeret udløsning |
Ciprofloxacin only product in oral dose form |
Ciprofloxacin 500mg prolonged-release oral tablet |
Ciprofloxacin only product in oral dose form |
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) |
Circulatory function test NOS |
Circulatory function tests (procedure) |
Circulatory function test NOS |
Circulatory function tests (procedure) |
Circumscribed scleroderma NOS |
Localised scleroderma |
Cisapride 1mg/mL suspension |
Cisapride 1 mg/mL oral suspension |
cisplatin 50 mg pulver til infusionsvæske, opløsning, hætteglas |
Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Cisplatin 50mg/vial powder for injection |
Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
citalopramhydrobromid 10 mg/5 ml opløsning |
Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
Citrate 6.5% conventional release eye drops |
Citric acid only product |
citrat 6,5 % øjendråber uden konserveringsmiddel |
Citric acid only product |
allergi over for citrat |
Allergy to citric acid (finding) |
Citrate monohydrate |
Citric acid monohydrate (substance) |
citronsyre + monohydrat + kaliumcitrat 550 mg + natriumcitrat 500 mg syrup |
Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
citronsyre 640 mg + natriumcitrat 490 mg |
Product containing citric acid and sodium citrate (medicinal product) |
citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitrat 500 mg syrup |
Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitratdihydrat 500 mg syrup |
Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
Citrobacter amalonaticus, biogroup 1 |
Citrobacter farmeri (organism) |
Citrobacter diversus |
Citrobacter koseri |
citrullinæmi, type med sen start |
A form of citrullinemia type I characterized clinically by adult onset of symptoms including variable hyperammonemia and less striking neurological findings which may include intense headache, scotomas, migraine-like episodes, ataxia, slurred speech, lethargy and drowsiness. Serious increased intracranial pressure may occur. |
Civil engineer NOS |
Civil engineer |
Civil engineer NOS |
Civil engineer |
Civil engineering equipment work NOS |
Civil engineer equipment work |
Civil engineering equipment work NOS |
Civil engineer equipment work |
Civil engineering technician (general) |
Civil engineering technician |
cladribin 1 mg/ml koncentrat til infusionsvæske, hætteglas a 10 ml |
Cladribine 1 mg/mL solution for injection |
Cladribine 1mg/mL injection |
Cladribine 1 mg/mL solution for injection |
Cladribine 1mg/mL injection solution 10mL vial |
Cladribine 1 mg/mL solution for injection |
Clam - dietary |
Clam (substance) |
pakning med clarithromycin 500 mg tablet og lansoprazol kapsel 30 mg og amoxyllin kapsel 500 mg |
Amoxicillin 500 mg oral capsule |
klassen Archaeobacteria |
Domain Archaea |
Class Cestoidea - subclass cestoda |
Subclass Eucestoda (organism) |
klassen Chloroflexi |
Class Chloroflexia (organism) |
Class Eurotiomycetes |
Subclass Eurotiomycetidae (organism) |
klassen Fibrobacteres |
Class Fibrobacteria |
Lentisphaerae |
Class Lentisphaeria (organism) |
Class Microsporea |
Phylum Microsporidia (organism) |
Class amphibia |
Class Amphibia (organism) |
Class arachnida |
Arachnid |
Class crustacea |
Subphylum Crustacea (organism) |
Class diplopoda |
Class Diplopoda (organism) |
Klassisk laparoskopisk Semm-hysterektomi |
Classic intrafascial supracervical hysterectomy (procedure) |
Classic mast cell leukemia |
Mast cell leukemia (clinical) |
Clavicular flap |
Flap (substance) |
Clavulanate potassium + ticarcillin disodium gm/gm injection |
Product containing clavulanic acid and ticarcillin (medicinal product) |
Clavulanate potassium gm/ticarcillin disodium gm injection solution vial |
Product containing clavulanic acid and ticarcillin (medicinal product) |
Clay/stone worker NOS |
Clay/stone worker |
Clay/stone worker NOS |
Clay/stone worker |
Clean environment |
Clean environment (finding) |
Cleaner for heated surfaces |
Cleaning agent (substance) |
toksisk virkning af rengøringsmiddel til opvarmede overflader |
Cleaning product causing toxic effect |
Rengøringsmateriale |
Cleaning agent (substance) |
Cleaning of animal penis |
Cleaning of penis |
rensning af hudsår, ikke klassificeret andetsteds |
Cleaning of wound of skin (procedure) |
Cleaning of skin wound NEC |
Cleaning of wound of skin (procedure) |
clear cell (mesonefroid) neoplasme iht. kategori |
Clear cell mesonephroid neoplasm |
clear cell-sarkom (i nyre (M-89643) undtaget) |
Clear cell sarcoma |
Clemastine 1.34mg tablet |
Clemastine fumarate 1.34 mg oral tablet |
clemastin 500 µg/5 ml eliksir |
Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug) |
clemastinfumarat 0,67 mg/5 ml syrup |
Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug) |
Clemastine+phenylpropanolamine 0.5/25mg tablet |
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet |
clemastin + phenylpropanolamin 0,5/25 mg tablet |
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet |
Clemmys insculpta |
Glyptemys insculpta (organism) |